Indegene — 360° view

Indegene, a company in the Healthcare Research, Analytics & Technology industry, reported revenue of ₹1,122 crore and net profit of ₹112 crore for the September 2026 quarter.

Indegene (NSE: INDGN) closed at ₹657.65 on 20 Nov 2026, up 27.7% over the past year. Its market capitalisation is ₹15,849 crore and it trades at 37.2 times earnings.

Share price
₹657.65 (20 Nov 2026)
Market cap
₹15,849 Cr (20 Nov 2026)
P/E
37.16 (20 Nov 2026)
Revenue
₹1,122 Cr (September 2026 quarter)
Net profit
₹112 Cr (September 2026 quarter)
ROCE
18.8% (FY26)
ROE
14.4% (FY26)
Book value
₹139 (FY26)
Dividend yield
0.34% (last 12 months to 20 Nov 2026)
52-week high / low
₹677.00 / ₹414.00 (20 Nov 2026)
1-year return
27.7% (to 20 Nov 2026)
Sector
Healthcare
Industry
Healthcare Research, Analytics & Technology
Symbol
NSE: INDGN

Incorporated in 1998, Indegene Ltd provides solutions consisting of analytics, technology and commercial, medical, regulatory and safety services to life science and health care organizations

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.